ABSTRACT
INTRODUCTION
Adiponectin, first identified in 1996, is a 244-amino acid protein that is abundantly expressed 26 in adipose tissue [1] . Having been shown to be related to lower incidence rates of type 2 27 diabetes and metabolic syndrome [2] , this adipocyte-derived hormone is believed to benefit 28 human health. Recently, however, increasing evidence from population-based studies indicates 29 that circulating adiponectin level is related to cardiovascular events and mortality in older 30 subjects [3, 4] . High circulating adiponectin concentration was also reported to be a predictor of 31 bone mineral density loss [5] and lung function decline [6] . Such epidemiological findings 32 indicate the potentially paradoxical involvement of adiponectin in health status. 33 Most recently, a population-based epidemiological study showed that the elderly with 34 relatively higher circulating adiponectin levels tended to have an increasing number of frailty 35 components compared to the elderly with relatively lower levels [7] . Furthermore, the potential 36 negative effect of adiponectin on physical function is supported by the findings of two 37 population-based prospective cohort studies that concur that relatively higher serum 38 adiponectin concentration contributes to incident physical disability in older subjects from the 39 United States [8] and Japan [9] . Based on these findings, an inverse correlation between 40 adiponectin and skeletal muscle function, an essential component of physical function, has 41 been hypothesized. Muscle strength decreased after the age of 50 and muscle strength loss is 42 most dramatic after 70 years old [10] . Evidence showed that the lower-extremity muscle 43 5 strength in older adults aged 75 years decreased by 16.5% during 2.8 years follow-up [11] . 44 Thus, decline of muscle strength with age become a major public health problem since lower 45 muscle strength is a predictor of mortality in the elderly [12] . 46 In a previous study, we identified an inverse association between serum adiponectin 47 concentration and upper-and lower-extremity muscle strength in middle-aged Japanese adults 48 [13] . Similar findings were reported by several other cross-sectional studies in which high 49 circulating adiponectin concentration was found to be associated with poor muscle strength in 50 European adolescents [14] and adults [15, 16] . Although an inverse association between 51 adiponectin concentration and muscle strength has been indicated, prospective research on this 
SUBJECTS AND METHODS

57
Study participants
58
The study participants were the participants of the Tsurugaya Project, a community-based 59 Comprehensive Geriatric Assessment (CGA) of Japanese aged ≥ 70 years who are living in the 60 Tsurugaya area of Sendai City, Japan. In brief, the CGA used a structured approach to measure 61 the physical, mental, and social functionings of older individuals to assess early deterioration in 62 long-term care conditions and promote healthy aging. The methods used in the Tsurugaya 63 Project have been reported in detail elsewhere [9, 17] . 
Serum adiponectin measurement
76
In this study, all blood samples were obtained under nonfasting conditions. It is has been that 77 circulating adiponectin did not differ between fasting and nonfasting conditions [18] . Serum 78 adiponectin concentration was determined by enzyme-linked immunosorbent assay (Otsuka 79 Pharmaceutical, Tokyo, Japan) or latex particle-enhanced turbidimetric immunoassay 80 (Mitsubishi Chemical Medience, Tokyo, Japan), the results of which were closely correlated (r 81 = 0.98) [19] . The intra-assay and inter-assay coefficients of variation were <10% for 82 enzyme-linked immunosorbent assay, and ≤2% for latex particle -enhanced turbidimetric 83 immunoassay. All assays were performed at a clinical testing laboratory (SRL, Tokyo, Japan). 
Physical function measurement
86
To assess skeletal muscle strength, maximal bilateral leg extension power was measured using 87 a dynamometer (Anaeropress 3500; Combi Co., Tokyo, Japan). After the subjects sat back on 88 the seat and placed both feet on the sliding footplate with the knee angle adjusted to 90°, a belt 89 was firmly fastened at the waist and the load of the footplate was set to their weight. The up-and-go test, which assesses mobility [22] , the subjects were required to rise from a 
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The participants' baseline characteristics are shown in Supplemental Table S1 . The mean It is important to emphasize that high serum adiponectin concentration was found to be 237 associated with poor performances in the functional reach and 10-m maximum walking speed 238 It is well-known that 229 muscle strength loss was a useful indicator of malnutrition [32] . Also, high levels of circulating 230 adiponectin may reflect poor nutrition status because adiponectin has been correlated with low 231 muscle mass [16] and circulating albumin levels [8] . Moreover, evidence indicated that 232 adiponectin predicts incidence of CVD in older people [3, 4] . According to these considerations, 233 it seems that poor nutrition status and cardiovascular function may mediate the observed 234 association, although the relationship between adiponectin and decline in lower-extremity 235 muscle strength was independent of serum albumin and history of CVD in this study. Several limitations of the present study should be considered when reviewing the findings. 
